Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm

British Journal of Clinical Pharmacology

Volumn 43, Issue 3, 1997, Pages 323-326

  Lyons, D ^a,d   Webster, J ^a   Nixon, A ^a   Young, M M R ^b   Smith, J ^b   Benjamin, N ^c  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

angiotensin receptor antagonist; GR117289C

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; PLACEBO; ZOLASARTAN;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; FOREARM BLOOD FLOW; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASOCONSTRICTION;

ADMINISTRATION, ORAL; ADULT; ANALYSIS OF VARIANCE; ANGIOTENSIN II; BLOOD PRESSURE; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FOREARM; HEART RATE; HUMANS; MALE; NICOTINIC ACIDS; RECEPTORS, ANGIOTENSIN; TETRAZOLES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0031044246     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Webb D, Benjamin N, Collier J, Robinson B. Enalapril induced cough [letter]. Lancet 1986; ii: 1094.
2. Hedner T, Samuelsson O, Lindholm L, Andren L, Wiholm BE. Angio-odema in relation to treatment with angiotensin converting enzyme inhibitors. Br Med J 1992; 304: 941-946.
3. Marshall GR, Vine W, Needleman P. A specific competitive inhibitor of angiotensin II. Proc Natl Acad Sci USA 1970; 67: 1624-1630.
4. Pals DT, Mosucci FD, Sipos F, Denning GS JR. A specific competitive antagonist of the vascular action of angiotensin II. Circ Res 1971; 29: 664-672.
5. Christen Y, Waeber B, Nussberger J, et al. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II. Circulation 1991; 83: 1333-42.
6. Christen Y, Waeber B, Nussberger J, Lee RJ, Timmermans PB, Brunner HR. Dose-response relationships following oral administration of DuP 753 to normal humans. Am J Hypertens 1991; 4(4 Pt 2): 350S-353S.
7. Robertson MJ, Middlemiss D, Ross BC, Drew GM, Scopes DIC, Dowle MD.GR117289: A novel potent and specific non peptide angiotensin receptor antagonist. Br J Pharmacol 1991; 104: 300P.
8. 1 receptor antagonist, GR117289C in healthy subjects. Br J Clin Pharmacol 1993; 35: 88P-89P.
9. Jamieson MJ, Webster J, Witte K, et al. An evaluation of the A&D UA-751 sphygmomanometer. J Hypertension 1990; 8: 607-619.
10. Whitney RJ. The measurement of volume changes in human limbs. J Physiol 1953; 121: 1-27.
11. Cockcroft JR, Sciberras DG, Goldberg MR, Ritter JM. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. J Cardiovasc Pharmacol 1993; 22: 579-584.